No role of the -2518 promoter polymorphism of monocyte chemotactic protein-1 in chronic hepatitis C.
Bonkovsky
Herbert L
HL
Salek
Jefrey
J
D000998:Antiviral Agents / Q000627:therapeutic use; D018932:Chemokine CCL2 / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000235:genetics*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D011092:Polyethylene Glycols; D011110:Polymorphism, Genetic; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*; D017384:Sequence Deletion
D000998:Antiviral Agents; C111835:CCL2 protein, human; D018932:Chemokine CCL2; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b